Despite flu admissions rising, Tamiflu fill rates are on the decline

As the U.S. reports an 80 percent hospital bed capacity, fill rates for common flu drug Tamiflu have slightly fallen since late November, GoodRx data shows. 

Nearly all states and regions are reporting very high or high levels of flu activity as the whole nation tackles hikes in influenza-like illness. In spite of the surge, the Tamiflu fill rate has dipped for the past two weeks as of the week ending Dec. 10. 

The American Society of Health-System Pharmacists noted Dec. 2 that five drugmakers were short on oseltamivir, the drug's generic name — the update was a minor improvement from the supply issue in early November. Tamiflu's drugmaker, Novo Nordisk, told Becker's in November the company has "sufficient supply" of the product, and CBS affiliate station WTSP reported the generic's shortage is sporadic and not nationwide. 

The FDA has not listed Tamiflu or oseltamivir products on its drug shortage database. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars